» Articles » PMID: 17506226

Hypertension, Cognitive Decline, and Dementia: an Epidemiological Perspective

Overview
Specialty Neurology
Date 2007 May 18
PMID 17506226
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertension is a known risk factor for stroke, and thus for vascular dementia. However, recent large observational studies have suggested that high blood pressure may also play a role in Alzheimer's disease. The mechanisms linking hypertension to Alzheimer's disease remain to be elucidated, but white matter lesions seen on cerebral magnetic resonance imaging appear to be a good marker of this association. It is not yet clearly established whether lowering blood pressure reduces the risk of white matter lesions and dementia, so large trials dealing with this question are eagerly awaited. These future trials could confirm the hope that, by lowering blood pressure, we may have a preventive treatment for dementia. This issue is of major importance, as the number of cases of dementia is expected to rise

Citing Articles

Toll-Like Receptor 4-Mediated Neuroinflammation: Updates on Pathological Roles and Therapeutic Strategies in Chronic Cerebral Hypoperfusion.

Yawoot N, Tocharus J, Tocharus C Mol Neurobiol. 2025; .

PMID: 39875782 DOI: 10.1007/s12035-025-04718-7.


Endothelium-related biomarkers and cognitive decline in prevalent hemodialysis patients: A prospective cohort study.

Liborio A, de Medeiros C, Santos L, de Andrade L, Meneses G, Martins A Eur J Neurol. 2024; 31(12):e16438.

PMID: 39136139 PMC: 11555003. DOI: 10.1111/ene.16438.


Peripheral vascular dysfunction and the aging brain.

Wahl D, Clayton Z Aging (Albany NY). 2024; 16(10):9280-9302.

PMID: 38805248 PMC: 11164523. DOI: 10.18632/aging.205877.


Frequency of Systemic Diseases and Oral Lesions Among the Institutionalized Elderly Subjects in the Northeast of Iran.

Dalirsani Z, Ghazi A, Firouzabadi M Indian J Dermatol. 2024; 68(6):723.

PMID: 38371557 PMC: 10868977. DOI: 10.4103/ijd.ijd_246_23.


Metabolic Disorder Therapeutics and their Effects on Memory.

Aggarwal P, Khan F, Banerjee S CNS Neurol Disord Drug Targets. 2023; 23(9):1061-1074.

PMID: 37921148 DOI: 10.2174/0118715273269329231013074613.


References
1.
Junque C, Pujol J, Vendrell P, Bruna O, Jodar M, RIBAS J . Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Arch Neurol. 1990; 47(2):151-6. DOI: 10.1001/archneur.1990.00530020047013. View

2.
Farmer M, Kittner S, Abbott R, Wolz M, Wolf P, White L . Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. J Clin Epidemiol. 1990; 43(5):475-80. DOI: 10.1016/0895-4356(90)90136-d. View

3.
Kozachuk W, DeCarli C, Schapiro M, Wagner E, Rapoport S, Horwitz B . White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study. Arch Neurol. 1990; 47(12):1306-10. DOI: 10.1001/archneur.1990.00530120050009. View

4.
van Swieten J, van den Hout J, van Ketel B, Hijdra A, Wokke J, van Gijn J . Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain. 1991; 114 ( Pt 2):761-74. DOI: 10.1093/brain/114.2.761. View

5.
. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991; 265(24):3255-64. View